Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00813488 · ClinicalTrials.gov registry record · Phase 3
Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain
A Phase 3 study, sponsored by Cephalon.
- Completed
- Registry status
- Phase 3
- Development phase
- 213
- Enrollment target
NCT00813488 is a Phase 3 study that has completed, run by Cephalon. The registered enrollment target is 213 participants.
The verdict
NCT00813488, a Phase 3 study, has completed, sponsored by Cephalon.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 213 participants
- Enrollment target
Study Summary
Evaluate the efficacy of treatment with the fentanyl buccal tablet (FBT) compared with immediate release oxycodone treatment in alleviating breakthrough pain (BTP) in opioid tolerant patients with chronic pain.
Interventions
- DRUG Fentanyl Buccal Tablet
- DRUG Immediate release oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00813488
The ClinicalTrials.gov registry entry for NCT00813488 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cephalon, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fentanyl Buccal Tablet is the first listed.
NCT00813488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00813488 about?
NCT00813488 is a clinical study titled "Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain". Evaluate the efficacy of treatment with the fentanyl buccal tablet (FBT) compared with immediate release oxycodone treatment in alleviating breakthrough pain (BTP) in opioid tolerant patients with chronic pain.
What is the current status of trial NCT00813488?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 213 participants. The study started on 2008-12. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00813488?
The interventions under investigation include: Fentanyl Buccal Tablet (DRUG), Immediate release oxycodone (DRUG).
Who is sponsoring clinical trial NCT00813488?
This trial is sponsored by Cephalon, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.